Charoen Pokphand Foods Public Company Limited (SET: CPF) has announced its 3Q25 consolidated financial statement through the Stock Exchange of Thailand as follows:
| Quarter | 3Q25 | 3Q24 |
| Net Profit (Loss)
Million Baht |
5,186.50 | 7,308.98 |
| Earning Per Share
(Baht) |
0.6400 | 0.9100 |
| % Change | -29.04 | |
| 9 Months | 2025 | 2024 |
| Net Profit (Loss)
Million Baht |
24,112.22 | 15,385.61 |
| Earning Per Share (Baht) | 3.0100 | 1.8800 |
| % Change | 56.72 | |
CPF reported a net profit of THB 5,186 million in the third quarter of 2025, representing a decrease of 29% compared to THB 7,309 million in the third quarter of 2024, due to the following reasons:
1) The losses on changes in fair value of biological assets of THB 1,115 million, compared to a gain of THB 733 million in the third quarter of 2024. The change was mainly due to the fair value adjustment of swine in Vietnam and Thailand.
2) Share of profit from associates and joint ventures amounted to THB 2,463 million, a decrease of 33%, primarily due to the lower performance of the associate in China, mainly driven by weak swine prices and the impact of a decline in the fair value of swine.
Sales revenue stood at THB 138,565 million, reflecting a 3% decrease compared to the same period last year, due to the effect of foreign currency translation of international operations financial statements resulting from the appreciation of the Thai Baht. Excluding the mentioned impact, sales revenue would have increased by 2% from the same period last year. The sales revenue comprised 61% from international operations and 39% from Thailand operations (which consisted of 33% from Thailand domestic operations and 6% from Thailand export operations).
Gross profit was THB 22,910 million, an increase of 4.4% from the same period last year. The gross profit margin rose from 15.4% in the third quarter of 2024 to 16.5%, driven by effective cost management and a decline in global soybean meal prices compared to the previous year, together with the company’s continued emphasis on production safety standards and strict disease prevention measures.
